Clinical Trial Update: Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the MODIFY Trial) [Phase 3]

View source ↗

Summary

Phase 3 MODIFY trial evaluating procalcitonin-guidance and molecular-guided diagnosis for therapy of severe infections; the study focusing on sepsis is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Hellenic Institute for the Study of Sepsis | Conditions: Sepsis | Phase 3 | Status: ACTIVE_NOT_RECRUITING